(1->4)-beta-D-glucan multiple interactions ISO RGD:732558 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of VDAC1 mRNA CTD PMID:36331819 (R)-adrenaline increases expression EXP 6480464 Epinephrine results in increased expression of VDAC1 protein CTD PMID:19464573 (R)-adrenaline multiple interactions EXP 6480464 [Epinephrine co-treated with Xanthine co-treated with XDH] results in increased expression of VDAC1 protein CTD PMID:19464573 1,2-dimethylhydrazine decreases expression ISO RGD:732558 6480464 1, 2-Dimethylhydrazine results in decreased expression of VDAC1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:732558 6480464 Ethinyl Estradiol affects the expression of VDAC1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression ISO RGD:732557 6480464 Ethinyl Estradiol results in increased expression of VDAC1 mRNA CTD PMID:18936297 17alpha-ethynylestradiol multiple interactions ISO RGD:732558 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of VDAC1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:732558 6480464 Ethinyl Estradiol results in increased expression of VDAC1 mRNA CTD PMID:17942748 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:732557 6480464 2 more ... CTD PMID:30714368 2,2,2-tetramine multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in increased expression of VDAC1 protein] CTD PMID:19634143 2,3',4,4',5-Pentachlorobiphenyl decreases expression ISO RGD:732558 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732558 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of VDAC1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of VDAC1 mRNA CTD PMID:32109520 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732558 6480464 Tetrachlorodibenzodioxin affects the expression of VDAC1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:732558 6480464 Tetrachlorodibenzodioxin results in decreased expression of VDAC1 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732558 6480464 Tetrachlorodibenzodioxin results in increased expression of VDAC1 mRNA CTD PMID:18796159 3,3',5-triiodo-L-thyronine multiple interactions ISO RGD:732558 6480464 Triiodothyronine promotes the reaction [bafilomycin A1 results in increased expression of VDAC1 protein] CTD PMID:30209975 3,3',5-triiodo-L-thyronine increases expression ISO RGD:732558 6480464 Triiodothyronine results in increased expression of VDAC1 protein CTD PMID:30209975 3,4-methylenedioxymethamphetamine increases expression ISO RGD:732558 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of VDAC1 mRNA CTD PMID:20188158 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of VDAC1 mRNA CTD PMID:28522335 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:732557 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VDAC1 mRNA CTD PMID:28628672 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid multiple interactions EXP 6480464 4 more ... CTD PMID:20937774 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid multiple interactions ISO RGD:732557 6480464 4 more ... CTD PMID:28343033 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of VDAC1 mRNA CTD PMID:36041667 4,4'-sulfonyldiphenol increases expression ISO RGD:732557 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of VDAC1 protein CTD PMID:34186270 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of VDAC1 mRNA CTD PMID:21346803 4-hydroxyphenyl retinamide increases expression ISO RGD:732558 6480464 Fenretinide results in increased expression of VDAC1 protein CTD PMID:28973697 7H-xanthine multiple interactions EXP 6480464 [Epinephrine co-treated with Xanthine co-treated with XDH] results in increased expression of VDAC1 protein CTD PMID:19464573 9H-xanthine multiple interactions EXP 6480464 [Epinephrine co-treated with Xanthine co-treated with XDH] results in increased expression of VDAC1 protein CTD PMID:19464573 acetylsalicylic acid affects expression EXP 6480464 Aspirin affects the expression of VDAC1 mRNA CTD PMID:12800193 Aflatoxin B2 alpha decreases methylation ISO RGD:732557 6480464 aflatoxin B2 results in decreased methylation of VDAC1 intron CTD PMID:30157460 aldehydo-D-glucose multiple interactions ISO RGD:732558 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of VDAC1 protein more ... CTD PMID:25488258 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of VDAC1 mRNA CTD PMID:16483693 antimycin A decreases expression ISO RGD:732557 6480464 Antimycin A results in decreased expression of VDAC1 mRNA CTD PMID:33512557 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of VDAC1 protein CTD PMID:21791222 arsenous acid multiple interactions EXP 6480464 Arsenic Trioxide promotes the reaction [VDAC1 protein binds to VDAC1 protein] CTD PMID:20937774 arsenous acid multiple interactions ISO RGD:732557 6480464 [Arsenic Trioxide results in increased expression of VDAC1 protein] which results in increased susceptibility to Cisplatin more ... CTD PMID:17374990 more ... arsenous acid increases expression ISO RGD:732557 6480464 Arsenic Trioxide results in increased expression of VDAC1 protein CTD PMID:22285227 arsenous acid increases ubiquitination ISO RGD:732558 6480464 Arsenic Trioxide results in increased ubiquitination of VDAC1 protein CTD PMID:24801902 asiatic acid multiple interactions ISO RGD:732557 6480464 asiatic acid inhibits the reaction [Hydrogen Peroxide results in increased expression of VDAC1 mRNA] more ... CTD PMID:18802751 ATP multiple interactions ISO RGD:732557 6480464 VDAC1 mutant form inhibits the reaction [chromium hexavalent ion results in decreased abundance of Adenosine Triphosphate] CTD PMID:22858589 azoxystrobin increases expression ISO RGD:732557 6480464 azoxystrobin results in increased expression of VDAC1 mRNA CTD PMID:33512557 bafilomycin A1 multiple interactions ISO RGD:732558 6480464 Triiodothyronine promotes the reaction [bafilomycin A1 results in increased expression of VDAC1 protein] CTD PMID:30209975 bafilomycin A1 increases expression ISO RGD:732558 6480464 bafilomycin A1 results in increased expression of VDAC1 protein CTD PMID:30209975 benzo[a]pyrene increases methylation ISO RGD:732557 6480464 Benzo(a)pyrene results in increased methylation of VDAC1 5' UTR, Benzo(a)pyrene results in increased methylation of VDAC1 promoter CTD PMID:27901495 betulinic acid multiple interactions ISO RGD:732557 6480464 [VDAC1 protein results in decreased susceptibility to Betulinic Acid] which results in increased expression of HK2 protein more ... CTD PMID:30136359 betulinic acid increases expression ISO RGD:732557 6480464 Betulinic Acid results in increased expression of VDAC1 protein CTD PMID:30136359 betulinic acid decreases response to substance ISO RGD:732557 6480464 VDAC1 protein results in decreased susceptibility to Betulinic Acid CTD PMID:30136359 bisphenol A increases expression ISO RGD:732558 6480464 bisphenol A results in increased expression of VDAC1 mRNA, bisphenol A results in increased expression of VDAC1 protein CTD PMID:36858637 bisphenol A decreases expression ISO RGD:732557 6480464 bisphenol A results in decreased expression of VDAC1 protein CTD PMID:34186270 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of VDAC1 mRNA CTD PMID:36041667 bisphenol A decreases methylation ISO RGD:732557 6480464 bisphenol A results in decreased methylation of VDAC1 gene CTD PMID:31601247 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of VDAC1 protein CTD PMID:32145629 bisphenol A multiple interactions ISO RGD:732558 6480464 VDAC1 promotes the reaction [bisphenol A results in decreased activity of SOD1 protein] more ... CTD PMID:36858637 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of VDAC1 mRNA CTD PMID:25181051 Bisphenol B increases expression ISO RGD:732557 6480464 bisphenol B results in increased expression of VDAC1 protein CTD PMID:34186270 bisphenol F multiple interactions ISO RGD:732557 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VDAC1 mRNA CTD PMID:28628672 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of VDAC1 mRNA CTD PMID:36041667 bisphenol F increases expression ISO RGD:732557 6480464 bisphenol F results in increased expression of VDAC1 protein CTD PMID:34186270 bortezomib decreases expression ISO RGD:732557 6480464 Bortezomib results in decreased expression of VDAC1 mRNA CTD PMID:20977926 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of VDAC1 protein CTD PMID:28903499 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of VDAC1 mRNA CTD PMID:19167457 cadmium atom increases expression ISO RGD:732557 6480464 Cadmium results in increased expression of VDAC1 protein CTD PMID:16440303 cadmium dichloride increases expression ISO RGD:732557 6480464 Cadmium Chloride results in increased expression of VDAC1 protein CTD PMID:16440303 cadmium dichloride increases expression ISO RGD:732558 6480464 Cadmium Chloride results in increased expression of VDAC1 mRNA, Cadmium Chloride results in increased expression of VDAC1 protein CTD PMID:36731763 cadmium dichloride multiple interactions ISO RGD:732558 6480464 1 more ... CTD PMID:20371981 , PMID:36731763 caffeine decreases expression ISO RGD:732557 6480464 Caffeine results in decreased expression of VDAC1 protein CTD PMID:31195006 calcidiol decreases expression EXP 6480464 Calcifediol deficiency results in decreased expression of VDAC1 mRNA CTD PMID:17293106 calcitriol multiple interactions EXP 6480464 [Calcium co-treated with Calcitriol] affects the expression of VDAC1 mRNA CTD PMID:15913539 calcium atom multiple interactions EXP 6480464 [Calcium co-treated with Calcitriol] affects the expression of VDAC1 mRNA CTD PMID:15913539 calcium(0) multiple interactions EXP 6480464 [Calcium co-treated with Calcitriol] affects the expression of VDAC1 mRNA CTD PMID:15913539 cannabidiol decreases expression ISO RGD:732557 6480464 Cannabidiol results in decreased expression of VDAC1 mRNA CTD PMID:27714895 carnosic acid multiple interactions ISO RGD:732557 6480464 PINK1 protein affects the reaction [salvin inhibits the reaction [Oxidopamine results in decreased expression of VDAC1 protein]], salvin inhibits the reaction [Oxidopamine results in decreased expression of and results in decreased ubiquitination of VDAC1 protein] CTD PMID:30707903 chloropicrin affects expression ISO RGD:732557 6480464 chloropicrin affects the expression of VDAC1 mRNA CTD PMID:26352163 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of VDAC1 mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:732558 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of VDAC1 gene CTD PMID:20938992 chromium(6+) affects expression ISO RGD:732557 6480464 chromium hexavalent ion affects the expression of VDAC1 mRNA CTD PMID:23057315 chromium(6+) increases expression ISO RGD:732557 6480464 chromium hexavalent ion results in increased expression of VDAC1 mRNA CTD PMID:22858589 chromium(6+) multiple interactions ISO RGD:732557 6480464 Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased expression of VDAC1 mRNA] more ... CTD PMID:22858589 cisplatin multiple interactions EXP 6480464 Cisplatin promotes the reaction [VDAC1 protein binds to VDAC1 protein] CTD PMID:20937774 cisplatin decreases expression ISO RGD:732557 6480464 Cisplatin results in decreased expression of VDAC1 mRNA CTD PMID:27594783 cisplatin multiple interactions ISO RGD:732557 6480464 [arsenic trioxide results in increased expression of VDAC1 protein] which results in increased susceptibility to Cisplatin CTD PMID:22285227 clobetasol increases expression ISO RGD:732558 6480464 Clobetasol results in increased expression of VDAC1 mRNA CTD PMID:27462272 clofibrate increases expression ISO RGD:732558 6480464 Clofibrate results in increased expression of VDAC1 mRNA CTD PMID:17585979 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of VDAC1 mRNA CTD PMID:17602206 clozapine decreases expression ISO RGD:732557 6480464 Clozapine results in decreased expression of VDAC1 protein CTD PMID:34122009 copper(II) chloride increases expression ISO RGD:732558 6480464 cupric chloride results in increased expression of VDAC1 protein CTD PMID:29617964 coumestrol increases expression ISO RGD:732557 6480464 Coumestrol results in increased expression of VDAC1 mRNA CTD PMID:19167446 curcumin multiple interactions ISO RGD:732557 6480464 Curcumin promotes the reaction [VDAC1 protein binds to VDAC1 protein] CTD PMID:28343033 cyclosporin A increases secretion ISO RGD:732558 6480464 Cyclosporine results in increased secretion of VDAC1 protein CTD PMID:21354196 D-glucose multiple interactions ISO RGD:732558 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of VDAC1 protein more ... CTD PMID:25488258 dexamethasone multiple interactions ISO RGD:732557 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VDAC1 mRNA CTD PMID:28628672 diallyl trisulfide decreases expression ISO RGD:732557 6480464 diallyl trisulfide results in decreased expression of VDAC1 protein CTD PMID:16344271 diarsenic trioxide multiple interactions EXP 6480464 Arsenic Trioxide promotes the reaction [VDAC1 protein binds to VDAC1 protein] CTD PMID:20937774 diarsenic trioxide increases expression ISO RGD:732557 6480464 Arsenic Trioxide results in increased expression of VDAC1 protein CTD PMID:22285227 diarsenic trioxide increases ubiquitination ISO RGD:732558 6480464 Arsenic Trioxide results in increased ubiquitination of VDAC1 protein CTD PMID:24801902 diarsenic trioxide multiple interactions ISO RGD:732557 6480464 [Arsenic Trioxide results in increased expression of VDAC1 protein] which results in increased susceptibility to Cisplatin more ... CTD PMID:17374990 more ... dibutyl phthalate increases expression ISO RGD:732558 6480464 Dibutyl Phthalate results in increased expression of VDAC1 mRNA CTD PMID:21266533 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of VDAC1 mRNA CTD PMID:17379624 , PMID:21266533 dioxygen increases expression ISO RGD:732558 6480464 Oxygen deficiency results in increased expression of VDAC1 protein, Oxygen results in increased expression of VDAC1 protein CTD PMID:25937538 , PMID:30529165 dioxygen multiple interactions ISO RGD:732558 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of VDAC1 protein more ... CTD PMID:25488258 , PMID:30529165 disodium selenite multiple interactions EXP 6480464 Sodium Selenite promotes the reaction [VDAC1 protein binds to VDAC1 protein] CTD PMID:20937774 disulfiram multiple interactions ISO RGD:732557 6480464 VDAC1 protein results in increased susceptibility to [arsenic trioxide co-treated with Ascorbic Acid co-treated with Disulfiram] CTD PMID:24126434 dopamine increases expression ISO RGD:732557 6480464 Dopamine results in increased expression of VDAC1 protein CTD PMID:24675778 dorsomorphin multiple interactions ISO RGD:732557 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VDAC1 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:732558 6480464 Doxorubicin results in decreased expression of VDAC1 mRNA, Doxorubicin results in decreased expression of VDAC1 protein CTD PMID:26873546 , PMID:34246718 doxorubicin multiple interactions ISO RGD:732557 6480464 3-(2 more ... CTD PMID:28456571 , PMID:29729358 doxorubicin decreases expression ISO RGD:732557 6480464 Doxorubicin results in decreased expression of VDAC1 protein CTD PMID:28456571 , PMID:29729358 efavirenz multiple interactions ISO RGD:732557 6480464 efavirenz promotes the reaction [VDAC1 protein binds to HSPA9 protein] CTD PMID:28940366 emodin decreases expression ISO RGD:732557 6480464 Emodin results in decreased expression of VDAC1 mRNA CTD PMID:16045814 Erythropoietin multiple interactions ISO RGD:732557 6480464 Erythropoietin inhibits the reaction [Doxorubicin results in decreased expression of VDAC1 protein], SIRT1 protein affects the reaction [Erythropoietin inhibits the reaction [Doxorubicin results in decreased expression of VDAC1 protein]] CTD PMID:28456571 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of VDAC1 protein CTD PMID:23702218 ethanol affects splicing ISO RGD:732558 6480464 Ethanol affects the splicing of VDAC1 mRNA CTD PMID:30319688 etoposide multiple interactions EXP 6480464 Etoposide promotes the reaction [VDAC1 protein binds to VDAC1 protein] CTD PMID:20937774 flufenoxuron increases expression ISO RGD:732558 6480464 flufenoxuron results in increased expression of VDAC1 protein CTD PMID:33771252 flutamide increases expression EXP 6480464 Flutamide results in increased expression of VDAC1 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:732558 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of VDAC1 gene CTD PMID:20938992 folpet increases expression ISO RGD:732558 6480464 folpet results in increased expression of VDAC1 mRNA CTD PMID:31558096 formaldehyde decreases expression ISO RGD:732557 6480464 Formaldehyde results in decreased expression of VDAC1 mRNA CTD PMID:23649840 furan affects binding EXP 6480464 furan binds to VDAC1 protein CTD PMID:22240984 genistein increases expression EXP 6480464 Genistein results in increased expression of VDAC1 mRNA CTD PMID:17341692 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of VDAC1 protein CTD PMID:22061828 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of VDAC1 mRNA CTD PMID:33387578 glucose multiple interactions ISO RGD:732558 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of VDAC1 protein more ... CTD PMID:25488258 GW 4064 multiple interactions ISO RGD:732558 6480464 GW 4064 inhibits the reaction [[caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of VDAC1 mRNA] CTD PMID:28223344 homocysteine increases expression ISO RGD:732557 6480464 Homocysteine results in increased expression of VDAC1 protein CTD PMID:33751715 homocysteine multiple interactions ISO RGD:732557 6480464 Homocysteine promotes the reaction [HSPA9 protein binds to VDAC1 protein] CTD PMID:33751715 hydrogen peroxide multiple interactions ISO RGD:732557 6480464 Acetylcysteine inhibits the reaction [Hydrogen Peroxide promotes the reaction [VDAC1 protein binds to VDAC1 protein]] more ... CTD PMID:18802751 , PMID:28343033 hydrogen peroxide multiple interactions EXP 6480464 Hydrogen Peroxide promotes the reaction [VDAC1 protein binds to VDAC1 protein] CTD PMID:20937774 hydrogen peroxide increases expression ISO RGD:732557 6480464 Hydrogen Peroxide results in increased expression of VDAC1 mRNA, Hydrogen Peroxide results in increased expression of VDAC1 protein CTD PMID:18802751 more ... hydrogen sulfide decreases expression ISO RGD:732558 6480464 Hydrogen Sulfide results in decreased expression of VDAC1 protein CTD PMID:29932956 indometacin multiple interactions ISO RGD:732557 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VDAC1 mRNA CTD PMID:28628672 ivermectin decreases expression ISO RGD:732557 6480464 Ivermectin results in decreased expression of VDAC1 protein CTD PMID:32959892 josamycin affects response to substance ISO RGD:732557 6480464 VDAC1 protein affects the susceptibility to Josamycin CTD PMID:31915244 L-ascorbic acid multiple interactions ISO RGD:732557 6480464 VDAC1 protein results in increased susceptibility to [arsenic trioxide co-treated with Ascorbic Acid co-treated with Disulfiram] CTD PMID:24126434 L-glutamic acid increases expression EXP 6480464 Glutamic Acid results in increased expression of VDAC1 mRNA CTD PMID:25797319 L-methionine multiple interactions ISO RGD:732558 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of VDAC1 gene CTD PMID:20938992 lamivudine multiple interactions ISO RGD:732558 6480464 [Zidovudine co-treated with Lamivudine] results in decreased expression of VDAC1 mRNA CTD PMID:18313992 lead diacetate decreases expression ISO RGD:732557 6480464 lead acetate results in decreased expression of VDAC1 protein CTD PMID:19822599 lead diacetate decreases expression ISO RGD:732558 6480464 lead acetate results in decreased expression of VDAC1 protein CTD PMID:20797405 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of VDAC1 mRNA, lead acetate results in decreased expression of VDAC1 protein CTD PMID:19822599 manganese atom increases expression ISO RGD:732558 6480464 Manganese deficiency results in increased expression of VDAC1 protein CTD PMID:21312047 manganese(0) increases expression ISO RGD:732558 6480464 Manganese deficiency results in increased expression of VDAC1 protein CTD PMID:21312047 melittin increases expression ISO RGD:732557 6480464 Melitten results in increased expression of VDAC1 protein CTD PMID:34375656 melphalan multiple interactions ISO RGD:732557 6480464 [arsenic trioxide results in increased expression of VDAC1 protein] which results in increased susceptibility to Melphalan CTD PMID:22285227 menadione affects expression ISO RGD:732557 6480464 Vitamin K 3 affects the expression of VDAC1 mRNA CTD PMID:20044591 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of VDAC1 protein CTD PMID:19826936 methyl methanesulfonate decreases expression ISO RGD:732557 6480464 Methyl Methanesulfonate results in decreased expression of VDAC1 mRNA CTD PMID:23649840 microcystin-LR increases expression EXP 6480464 cyanoginosin LR results in increased expression of VDAC1 mRNA, cyanoginosin LR results in increased expression of VDAC1 protein CTD PMID:31157505 mitoxantrone decreases expression ISO RGD:732558 6480464 Mitoxantrone results in decreased expression of VDAC1 protein CTD PMID:34246718 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine decreases expression EXP 6480464 N more ... CTD PMID:21605504 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine increases expression EXP 6480464 N more ... CTD PMID:21605504 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions EXP 6480464 Zinc Sulfate inhibits the reaction [N more ... CTD PMID:21605504 N-acetyl-L-cysteine multiple interactions ISO RGD:732557 6480464 Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased expression of VDAC1 mRNA] more ... CTD PMID:22858589 more ... N-ethylmaleimide affects binding EXP 6480464 Ethylmaleimide binds to VDAC1 protein CTD PMID:20192921 N-hexadecanoylsphingosine multiple interactions ISO RGD:732558 6480464 [N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of VDAC1 mRNA, ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of VDAC1 mRNA] CTD PMID:28223344 N-methyl-4-phenylpyridinium affects expression ISO RGD:732557 6480464 1-Methyl-4-phenylpyridinium affects the expression of VDAC1 mRNA CTD PMID:12710931 N-methyl-4-phenylpyridinium increases expression ISO RGD:732557 6480464 1-Methyl-4-phenylpyridinium results in increased expression of VDAC1 protein CTD PMID:24675778 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of VDAC1 mRNA CTD PMID:17602206 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of VDAC1 mRNA CTD PMID:24136188 ochratoxin A decreases expression ISO RGD:732557 6480464 ochratoxin A results in decreased expression of VDAC1 mRNA CTD PMID:34748853 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of VDAC1 mRNA CTD PMID:25729387 oxidopamine multiple interactions ISO RGD:732557 6480464 Oxidopamine results in decreased expression of and results in decreased ubiquitination of VDAC1 protein more ... CTD PMID:30707903 oxybenzone decreases expression EXP 6480464 oxybenzone results in decreased expression of VDAC1 mRNA CTD PMID:30316929 p-menthan-3-ol decreases expression ISO RGD:732557 6480464 Menthol results in decreased expression of VDAC1 mRNA CTD PMID:26760959 p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of VDAC1 mRNA CTD PMID:27638505 paracetamol decreases expression ISO RGD:732558 6480464 Acetaminophen results in decreased expression of VDAC1 mRNA CTD PMID:17585979 paracetamol increases expression ISO RGD:732558 6480464 Acetaminophen results in increased expression of VDAC1 protein CTD PMID:21329376 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:21673325 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:732558 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of VDAC1 mRNA, perfluorooctane sulfonic acid inhibits the reaction [ITPR1 protein binds to HSPA9 protein binds to VDAC1 protein] CTD PMID:28288859 , PMID:36331819 peroxynitrous acid multiple interactions EXP 6480464 Peroxynitrous Acid promotes the reaction [VDAC1 protein modified form binds to VDAC1 protein modified form] more ... CTD PMID:22709907 phenethyl caffeate multiple interactions ISO RGD:732558 6480464 [caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of VDAC1 mRNA more ... CTD PMID:28223344 phosphoramide mustard affects expression EXP 6480464 phosphoramide mustard affects the expression of VDAC1 mRNA CTD PMID:26708502 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of VDAC1 mRNA CTD PMID:19162173 Propiverine affects binding EXP 6480464 propiverine binds to VDAC1 protein CTD PMID:29273565 pyrazinecarboxamide increases expression EXP 6480464 Pyrazinamide results in increased expression of VDAC1 mRNA CTD PMID:22431067 pyrogallol increases expression ISO RGD:732558 6480464 Pyrogallol results in increased expression of VDAC1 mRNA CTD PMID:20362636 quercetin increases expression ISO RGD:732557 6480464 Quercetin results in increased expression of VDAC1 protein CTD PMID:17292933 reactive oxygen species multiple interactions ISO RGD:732557 6480464 VDAC1 inhibits the reaction [ME-344 results in increased abundance of Reactive Oxygen Species] CTD PMID:32546528 resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [Peroxynitrous Acid results in increased metabolism of VDAC1 protein] CTD PMID:22709907 resveratrol decreases response to substance ISO RGD:732558 6480464 VDAC1 protein results in decreased susceptibility to resveratrol CTD PMID:25488258 resveratrol multiple interactions ISO RGD:732558 6480464 resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of VDAC1 protein], VDAC1 protein inhibits the reaction [resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]] CTD PMID:25488258 rotenone multiple interactions ISO RGD:732557 6480464 asiatic acid inhibits the reaction [Rotenone results in increased expression of VDAC1 mRNA], asiatic acid inhibits the reaction [Rotenone results in increased expression of VDAC1 protein] CTD PMID:18802751 rotenone increases expression EXP 6480464 Rotenone results in increased expression of VDAC1 protein CTD PMID:28532211 , PMID:35544339 rotenone increases expression ISO RGD:732557 6480464 Rotenone results in increased expression of VDAC1 mRNA, Rotenone results in increased expression of VDAC1 protein CTD PMID:18802751 sarin increases expression ISO RGD:732557 6480464 Sarin results in increased expression of VDAC1 mRNA CTD PMID:19522546 saxitoxin decreases expression ISO RGD:732558 6480464 Saxitoxin results in decreased expression of VDAC1 protein CTD PMID:29228856 SB 431542 multiple interactions ISO RGD:732557 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VDAC1 mRNA CTD PMID:27188386 sertraline affects binding ISO RGD:732557 6480464 Sertraline binds to VDAC1 protein CTD PMID:33124469 sertraline multiple interactions ISO RGD:732558 6480464 VDAC1 protein affects the reaction [Sertraline results in decreased phosphorylation of MTOR protein], VDAC1 protein affects the reaction [Sertraline results in decreased phosphorylation of RPS6KB1 protein] CTD PMID:33124469 simvastatin decreases expression EXP 6480464 Simvastatin results in decreased expression of VDAC1 protein CTD PMID:20217863 sodium fluoride decreases expression EXP 6480464 Sodium Fluoride results in decreased expression of VDAC1 protein CTD PMID:29653260 staurosporine multiple interactions EXP 6480464 4 more ... CTD PMID:20937774 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of VDAC1 protein CTD PMID:19634143 streptozocin multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in increased expression of VDAC1 protein] CTD PMID:19634143 sulforaphane multiple interactions ISO RGD:732558 6480464 NFE2L2 protein affects the reaction [sulforaphane promotes the reaction [Oxygen results in increased expression of VDAC1 protein]], sulforaphane promotes the reaction [Oxygen results in increased expression of VDAC1 protein] CTD PMID:30529165 T-2 toxin affects expression EXP 6480464 T-2 Toxin affects the expression of VDAC1 protein CTD PMID:26141394 tamoxifen affects expression ISO RGD:732558 6480464 Tamoxifen affects the expression of VDAC1 mRNA CTD PMID:17555576 tauroursodeoxycholic acid multiple interactions ISO RGD:732558 6480464 ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of VDAC1 mRNA] CTD PMID:28223344 thapsigargin decreases expression ISO RGD:732557 6480464 Thapsigargin results in decreased expression of VDAC1 mRNA CTD PMID:22378314 titanium dioxide decreases expression ISO RGD:732558 6480464 titanium dioxide results in decreased expression of VDAC1 mRNA CTD PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of VDAC1 mRNA CTD PMID:25729387 Tributyltin oxide decreases expression EXP 6480464 bis(tri-n-butyltin)oxide results in decreased expression of VDAC1 mRNA CTD PMID:17553608 trichostatin A increases expression ISO RGD:732557 6480464 trichostatin A results in increased expression of VDAC1 mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:732557 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VDAC1 mRNA CTD PMID:27188386 trimellitic anhydride increases expression ISO RGD:732558 6480464 trimellitic anhydride results in increased expression of VDAC1 mRNA CTD PMID:19042947 troglitazone increases expression ISO RGD:732558 6480464 troglitazone results in increased expression of VDAC1 protein CTD PMID:18495193 , PMID:28973697 tunicamycin decreases expression ISO RGD:732557 6480464 Tunicamycin results in decreased expression of VDAC1 mRNA CTD PMID:22378314 valproic acid decreases expression ISO RGD:732557 6480464 Valproic Acid results in decreased expression of VDAC1 mRNA CTD PMID:19101580 valproic acid increases methylation ISO RGD:732557 6480464 Valproic Acid results in increased methylation of VDAC1 gene CTD PMID:29154799 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of VDAC1 mRNA CTD PMID:23665938 venlafaxine hydrochloride increases expression EXP 6480464 Venlafaxine Hydrochloride results in increased expression of VDAC1 mRNA CTD PMID:25423262 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of VDAC1 promoter CTD PMID:22570695 zearalenone increases expression ISO RGD:732558 6480464 Zearalenone results in increased expression of VDAC1 protein CTD PMID:34716709 zidovudine multiple interactions ISO RGD:732558 6480464 [Zidovudine co-treated with Lamivudine] results in decreased expression of VDAC1 mRNA CTD PMID:18313992 zinc oxide increases expression ISO RGD:732558 6480464 Zinc Oxide results in increased expression of VDAC1 mRNA CTD PMID:33236829 zinc sulfate multiple interactions EXP 6480464 Zinc Sulfate inhibits the reaction [N more ... CTD PMID:21605504